Stock Analysis

Bullish Perimeter Medical Imaging AI Insiders Loaded Up On US$3.51m Of Stock

TSXV:PINK
Source: Shutterstock

Quite a few insiders have dramatically grown their holdings in Perimeter Medical Imaging AI, Inc. (CVE:PINK) over the past 12 months. An insider's optimism about the company's prospects is a positive sign.

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

View our latest analysis for Perimeter Medical Imaging AI

The Last 12 Months Of Insider Transactions At Perimeter Medical Imaging AI

The insider Rocco Schiralli made the biggest insider purchase in the last 12 months. That single transaction was for CA$3.4m worth of shares at a price of CA$0.42 each. So it's clear an insider wanted to buy, at around the current price, which is CA$0.46. That means they have been optimistic about the company in the past, though they may have changed their mind. While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. Happily, the Perimeter Medical Imaging AI insiders decided to buy shares at close to current prices.

While Perimeter Medical Imaging AI insiders bought shares during the last year, they didn't sell. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
TSXV:PINK Insider Trading Volume January 13th 2025

Perimeter Medical Imaging AI is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.

Does Perimeter Medical Imaging AI Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our data indicates that Perimeter Medical Imaging AI insiders own about CA$5.9m worth of shares (which is 14% of the company). We do generally prefer see higher levels of insider ownership.

What Might The Insider Transactions At Perimeter Medical Imaging AI Tell Us?

There haven't been any insider transactions in the last three months -- that doesn't mean much. But insiders have shown more of an appetite for the stock, over the last year. We'd like to see bigger individual holdings. However, we don't see anything to make us think Perimeter Medical Imaging AI insiders are doubting the company. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. To that end, you should learn about the 5 warning signs we've spotted with Perimeter Medical Imaging AI (including 1 which makes us a bit uncomfortable).

But note: Perimeter Medical Imaging AI may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.